ArticleBMC pulmonary medicine2026

Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease.

Shiho Goda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.